TrueBinding, Inc.
7 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's Disease (NCT06773962) | TrueBinding, Inc. | 2025-03-20 |
| A Long Term Extension Study to Assess the Safety of TB006 in Participants With Alzheimer's Disease (NCT05476783) | TrueBinding, Inc. | 2022-09-15 |
| A Study to Assess the Efficacy, Safety, and Pharmacokinetics of TB006 in Participants With Acute Ischemic Stroke (NCT05156827) | TrueBinding, Inc. | 2022-07-26 |
| Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of TB006 in Participants With Alzheimer's Disease (NCT05074498) | TrueBinding, Inc. | 2021-10-08 |
| Sequential Dose-escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of TB006 in Healthy Subjects (NCT04920786) | TrueBinding, Inc. | 2021-06-01 |
| Study of TB006 in Outpatient Patients With Mild to Moderate COVID-19 (NCT04801056) | TrueBinding, Inc. | 2021-06-01 |
Track TrueBinding, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.